Synmosa Biopharma Current Assets

Synmosa Biopharma (4114.TWO) currently reports a current assets of $7.1B as of June 2026. That compares with $6.8B in the prior-year period — up 4.0% year over year. Use the charts on this page to explore Synmosa Biopharma's current assets history and peer comparisons.

Synmosa Biopharma's current assets increased from $6.8B to $7.1B — a 4.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Synmosa Biopharma reported $7.1B in current assets as of June 2026. That compares with $6.8B in the prior-year period — up 4.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $7.1B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Synmosa Biopharma, and consider following 4114.TWO for alerts when major investors trade the stock.